Mangoceuticals, Common Stock Stock Probability of Future Stock Price Finishing Over 2.43
| MGRX Stock | 2.50 0.03 1.19% |
Mangoceuticals, |
Mangoceuticals, Common Target Price Odds to finish over 2.43
The tendency of Mangoceuticals, Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above 2.43 in 90 days |
| 2.50 | 90 days | 2.43 | about 82.29 |
Based on a normal probability distribution, the odds of Mangoceuticals, Common to stay above 2.43 in 90 days from now is about 82.29 (This Mangoceuticals, Common Stock probability density function shows the probability of Mangoceuticals, Stock to fall within a particular range of prices over 90 days) . Probability of Mangoceuticals, Common price to stay between 2.43 and its current price of 2.5 at the end of the 90-day period is roughly 2.8 .
Given the investment horizon of 90 days Mangoceuticals, Common Stock has a beta of -0.11. This indicates as returns on the benchmark increase, returns on holding Mangoceuticals, Common are expected to decrease at a much lower rate. During a bear market, however, Mangoceuticals, Common Stock is likely to outperform the market. Additionally Mangoceuticals, Common Stock has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Mangoceuticals, Common Price Density |
| Price |
Predictive Modules for Mangoceuticals, Common
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mangoceuticals, Common. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Mangoceuticals, Common Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Mangoceuticals, Common is not an exception. The market had few large corrections towards the Mangoceuticals, Common's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mangoceuticals, Common Stock, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mangoceuticals, Common within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.23 | |
β | Beta against Dow Jones | -0.11 | |
σ | Overall volatility | 0.68 | |
Ir | Information ratio | -0.06 |
Mangoceuticals, Common Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mangoceuticals, Common for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mangoceuticals, Common can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Mangoceuticals, Common generated a negative expected return over the last 90 days | |
| Mangoceuticals, Common has high historical volatility and very poor performance | |
| Mangoceuticals, Common has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 731.49 K. Net Loss for the year was (9.21 M) with profit before overhead, payroll, taxes, and interest of 4.85 K. | |
| Mangoceuticals, Common generates negative cash flow from operations | |
| About 37.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Eugene Johnston of 25000 shares of Mangoceuticals, Common subject to Rule 16b-3 |
Mangoceuticals, Common Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mangoceuticals, Stock often depends not only on the future outlook of the current and potential Mangoceuticals, Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mangoceuticals, Common's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.4 M | |
| Cash And Short Term Investments | 739 K |
Mangoceuticals, Common Technical Analysis
Mangoceuticals, Common's future price can be derived by breaking down and analyzing its technical indicators over time. Mangoceuticals, Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mangoceuticals, Common Stock. In general, you should focus on analyzing Mangoceuticals, Stock price patterns and their correlations with different microeconomic environments and drivers.
Mangoceuticals, Common Predictive Forecast Models
Mangoceuticals, Common's time-series forecasting models is one of many Mangoceuticals, Common's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Mangoceuticals, Common's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Mangoceuticals, Common
Checking the ongoing alerts about Mangoceuticals, Common for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mangoceuticals, Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Mangoceuticals, Common generated a negative expected return over the last 90 days | |
| Mangoceuticals, Common has high historical volatility and very poor performance | |
| Mangoceuticals, Common has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 731.49 K. Net Loss for the year was (9.21 M) with profit before overhead, payroll, taxes, and interest of 4.85 K. | |
| Mangoceuticals, Common generates negative cash flow from operations | |
| About 37.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Eugene Johnston of 25000 shares of Mangoceuticals, Common subject to Rule 16b-3 |
Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.